Please note that this meeting will take place as an in-person event in Montréal and will not live-stream content for virtual participation. The meeting content will be recorded and made available as an on-demand program after the conference.

All presentations are scheduled to be live, in-person presentations at the date and time specified below unless noted otherwise.  Program in progress.

Friday, July 7, 2023

• Plenary Session 1: TME & Immunobiology
• Plenary Session 2: Next Generation Radiotherapy
• Optional Grant Writing Panel Discussion
• Plenary Session 3: Genomics: Beyond DNA
• Keynote Lecture

Saturday, July 8, 2023

• Plenary Session 4: Imaging & Biomarkers
• Plenary Session 5: Clinical Trials
• Closing Keynote Lecture
• Optional Post-event Workshop: Clinical Trial Design Panel Discussion

Friday, july 7, 2023

Breakfast
7-8 A.M.

Welcome & Opening Remarks
8-8:10 A.M.

Joseph A. Califano, UC San Diego, San Diego, California

Plenary Session 1: TME & Immunobiology
Session Chair: Ravindra Uppaluri, Dana-Farber Cancer Institute, Boston, Massachusetts
8:10-10 A.M.

Title to be announced 
Eric Tran, Earle A. Chiles Research Institute, Portland, Oregon

Title to be announced
Moran Amit, UT MD Anderson Cancer Center, Houston, Texas

Title to be announced 
Christian S. Hinrichs, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey

Short talks from proffered abstracts

Break
10-10:15 A.M.

Plenary Session 2: Next Generation Radiotherapy
Session Chair: To be announced
10:15 A.M.-12 P.M.

Title to be announced
Sana D. Karam, University of Colorado Denver, Denver, Colorado

Rational therapeutic de-escalation for HPV-related oropharynx cancer and therapeutic intensification for recurrent head and neck cancer
Yvonne M. Mowry, University of Pittsburgh, Pittsburgh, Pennsylvania        

Title to be announced
Andrew B. Sharabi, UCSD Moores Cancer Center, La Jolla, California

Short talks from proffered abstracts

Lunch (on own)
12-2 P.M.

Optional Grant Writing Panel Discussion
12:45 p.m.–1:45 p.m. 

Jennifer Rubin Grandis, University of California San Francisco, San Francisco, California

Xiao-Jing Wang, UC Davis Comprehensive Cancer Center, Sacramento, California

Plenary Session 3: Genomics: Beyond DNA
Session Chair: Cherie-Ann O. Nathan, LSU Health Sciences Center – Shreveport, Shreveport, Louisiana
2-4 P.M.  

Heterogeneity in HPV+ oropharynx cancers: An opportunity for rational (de)escalation
Sidharth V. Puram, Washington University School of Medicine in St. Louis, St. Louis, Missouri

Title to be announced
Luc G.T. Morris, Memorial Sloan Kettering Cancer Center, New York, New York

Title to be announced
Jennifer Rubin Grandis, University of California San Francisco, San Francisco, California

Short talks from proffered abstracts

Keynote Lecture
Session Chair: Andrean L. Simons-Burnett, University of Iowa, Iowa City, Iowa
3:45-4:30 P.M. 

Speaker to be announced

Poster Session/Reception
4-6 P.M.

Saturday, july 8, 2023

BREAKFAST
7-8 A.M.

PLENARY SESSION 4: imaging and biomarkers
Session Chair: Carole Fakhry, Johns Hopkins Medicine, Baltimore, Maryland
8-9:30 A.M.

New frontiers in head and neck cancer
Maie St John, UCLA David Geffen School of Medicine, Los Angeles, California

Molecular response and cellular targeting of antibody-targeted therapies: Are barriers to antibody delivery limiting therapeutic effect in solid tumors?
Eben Rosenthal, Vanderbilt University School of Medicine, Nashville, Tennessee

Title to be announced
Christine H. Chung, H. Lee Moffitt Cancer Center, Tampa, Florida

Short talk from proffered abstracts

BREAK
9:30-9:45 A.M.

PLENARY SESSION 5: Clinical trials
Session Chair: Nicole C. Schmitt, Emory Winship Cancer Institute, Atlanta, Georgia
9:45-11:25 A.M.

Title to be announced
Barbara A. Burtness, Yale School of Medicine, New Haven, Connecticut

Clinical trials in head and neck cancer
Sue S. Yom, UCSF School of Medicine, San Francisco, California

Checkpoint blockade in recurrent and metastatic head and neck cancer
Robert I. Haddad, Dana-Farber Cancer Institute, Boston, Massachusetts

Short talk from proffered abstracts

Closing Keynote Lecture
Session Chair: Sana D. Karam, University of Colorado Denver, Denver, Colorado 
11:25 A.M.-12:10 P.M.

Speaker to be announced

Closing Remarks
12:10-12:20 P.M.

Jose P. Zevallos, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

Optional Post-event workshop: Clinical Trial Design Panel Discussion
12:30-1:30 P.M.

Panelists to be announced